Li, M
Seiser, E L
Baldwin, R M
Ramirez, J
Ratain, M J
Innocenti, F
Kroetz, D L
Article History
Received: 29 November 2015
Revised: 9 May 2016
Accepted: 25 August 2016
First Online: 15 November 2016
Competing interests
: Drs Innocenti and Ratain are patent holders on the UGT1A1 testing for irinotecan neutropenia. Dr Ratain also receives intermittent royalties on multiple patents related to irinotecan pharmacogenetics and is an inventor on a pending patent application for a genomic prescribing system. The remaining authors declare no conflict of interest.